Age-related effects of scopolamine on REM sleep regulation in normal control subjects: relationship to sleep abnormalities in depression.
In order to assess the influence of development on the regulation of rapid eye movement (REM) sleep by cholinergic systems, the REM sleep responses to scopolamine were assessed in five normal adolescent and seven adult control subjects in this preliminary investigation. Subjects were studied on two separate occasions for three consecutive nights. Subjects received placebo or scopolamine (1.5 ug/kg, i.m.) on night 2; night 3 was considered the "recovery" night. As expected, scopolamine delayed REM latency and suppressed REM sleep on night 2 in both the adolescents and adults. Subtle developmental differences occurred, with scopolamine having a tendency to suppress REM sleep less effectively in younger subjects. On night 3, REM latency was shortened and REM sleep was increased to comparable extent in both the adolescents and adults. The comparable REM sleep responses to scopolamine between normal adolescents and adults, particularly on night 3, are discussed in relation to the age-related expression of REM sleep abnormalities in depression.
Rao
U
U
Department of Psychiatry, Harbor-UCLA Medical Center, Torrance, USA.
Lutchmansingh
P
P
Poland
R E
RE
D000293:Adolescent; D000328:Adult; D000375:Aging / Q000502:physiology*; D000704:Analysis of Variance; D003863:Depression; D004569:Electroencephalography / Q000187:drug effects; D006801:Humans; D012016:Reference Values; D012601:Scopolamine / Q000494:pharmacology*; D012893:Sleep Wake Disorders; D012895:Sleep, REM / Q000187:drug effects* / Q000502:physiology
D012601:Scopolamine